AstraZeneca hikes dividend as shareholders vote on CEO’s pay
Pharmaceutical giant AstraZeneca announced a 7% increase in the annualised dividend to $3.10 per share which the board said, 'underlined the company's confidence in its performance and cash generation'.
Chairman Michel Demare explained that the increase is in line with the firm's 'progressive' dividend policy which remains unchanged.
The shares traded 1.3% higher to £108.74 taking the gains...